FDA Official Says ‘Simple Reform’ Not A Step Back From Program Alignment

 
• By Derrick Gingery
  
US FDA acting deputy associate commissioner Elizabeth Miller said the planned 'Simple Reform' will enhance the program alignment initiative rather than undo it. (Shutterstock)

More from US FDA

More from Medtech Insight